Yunjeong Choi

Yunjeong Choi

Auto-generated profile, based on publicly available information

Yunjeong Choi

Department of Biomedical Engineering, Kyung Hee University, Yongin, Republic of Korea

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2025 in eClinicalMedicine
Verified
Journal Article
Open access
HLHayeon Lee
Hayeon Lee
SHSeung Ha Hwang
Seung Ha Hwang
SPSeoyoung Park
Seoyoung Park
YCYunjeong Choi
Yunjeong Choi
SLSooji Lee
Sooji Lee
DYDong Keon Yon
Dong Keon Yon
Type 2 diabetes mellitus (T2DM) is a significant global public health concern that has steadily increased over the past few decades. Thus, this study aimed to predict the incidence of T2DM within 5 years and the risk of mortality following the onset of T2DM. Data from three independent cohorts worldwide were used. We utilized data from three independent, large-scale, general population-based, and worldwide cohort studies. The Korean cohort (NHIS-NSC cohort; discovery cohort; n = 973,303), conducted between 1 January, 2002 and 31 December, 2013, was used for training and internal validation, whereas the Japanese cohort (JMDC cohort; validation cohort A; n = 12,143,715) and UK cohort (UK Biobank; validation cohort B; n = 416,656) were used for external validation. We employed various machine learning (ML)-based models, using 18 features, to predict the incidence of T2DM within five years of regular health checkups and calculated the Shapley Additive Explanation (SHAP) values. To ensure the robustness of our ML-based prediction model, we investigated the potential association between the model probability divided into tertiles and the risk of mortality following the onset of T2DM. In the discovery cohort, the ensemble model using voting with logistic regression and adaptive boosting achieved a balanced accuracy of 72.6% and an area under the receiver operating characteristics curve (AUROC) of 0.792. The SHAP value analysis of our proposed model revealed that age was the most important predictor of incident T2DM, followed by fasting blood glucose, hemoglobin, γ-glutamyl transferase level, and body mass index. The model probability is associated with an increased risk of mortality (T1: adjusted hazard ratio, 2.82 [95% CI, 2.01–3.94]; T2: 3.89 [2.74–5.53]; and T3: 7.73 [5.37–11.12]). Similar patterns and trends were observed in the validation cohorts (T1: 1.74 [1.49–2.03], T2: 1.97 [1.69–2.30], and T3: 3.31 [2.82–3.38] in validation cohort A; T1: 1.33 [1.03–1.71], T2: 1.54 [1.21–1.96], and T3: 1.73 [1.36–2.20] in validation cohort B). This study derived and validated an ML-based model to predict the incidence of T2DM within 5 years across three countries (South Korea, Japan, and the UK), showing that the model probability is associated with an increased risk of mortality. Institute of Information & Communications Technology Planning & Evaluation, South Korea.

13 March 2026 in EBioMedicine
Verified
Journal Article
Open access
YCYunjeong Choi
Yunjeong Choi
JSJunepill Seok
Junepill Seok
TOThomas Young-Chul Oh
Thomas Young-Chul Oh
JHJeremy Hsu
Jeremy Hsu
DKDo Wan Kim
Do Wan Kim
Jinseok LeeJinseok Lee
Jinseok Lee
Accurate and equitable prediction of trauma-related in-hospital mortality is critical for guiding clinical decisions and optimising trauma care resources. Traditional severity scoring systems like the Injury Severity Score (ISS) do not account for demographic factors, potentially limiting their fairness and generalisability across diverse populations. We developed and externally validated an artificial intelligence (AI) model based on ISS and integrated demographic features (age and sex) to predict in-hospital mortality after trauma. Data from the Korean Trauma Data Bank were used for model development and internal validation, comprising 121,418 patients with trauma aged ≥15 years treated at 19 trauma centres in South Korea (2017-2022). External validation was performed on an independent cohort of 7458 patients from five trauma centres (four in South Korea and one in Australia, 2022-2024). The primary outcome was trauma-related in-hospital mortality. Predictive performance was assessed using area under the receiver operating characteristic curve (AUROC), sensitivity, specificity, accuracy, and balanced accuracy. Fairness was evaluated by comparing AUROC differences across age (<65 vs ≥65 years) and sex (female vs male) subgroups. The ISS-based AI model incorporating age and sex achieved high predictive performance (internal validation AUROC, 0.934; external validation AUROC range, 0.901-0.920), outperforming conventional ISS-based methods. The model also demonstrated improved fairness, showing reduced AUROC differences across subgroups (age: 0.068 vs 0.091; sex: 0.021 vs 0.046 for AI model vs ISS, respectively). Scaling an ISS-based AI model through demographic integration yielded accurate, fair, and generalisable predictions of trauma-related in-hospital mortality. This approach may enhance trauma care decision-making and enable more equitable resource allocation across diverse clinical settings. This research was supported by the MSIT (Ministry of Science and ICT), Korea, under the ITRC (Information Technology Research Center) support program (IITP-2025-RS-2024-00438239) and the Institute of Information & Communications Technology Planning & Evaluation (IITP) grant funded by the Korea government (MSIT) (RS-2024-00509257, Global AI Frontier Lab). In addition, this research was supported by the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (RS-2025-02220492).